−0.043 AUD
−2.34 M AUD
0.00 AUD
About VECTUS BIOSYSTEMS LIMITED
Sector
Industry
Headquarters
Rosebery
Website
Founded
2005
ISIN
AU000000VBS9
FIGI
BBG00BJMG589
Vectus Biosystems Ltd. is a drug discovery and development company, which engages in the treatment for fibrosis and high blood pressure, which includes therapeutics for diseases in the fibrotic market namely heart, kidney, and liver disease. Its lead compounds include VB0004, VB4-A32, VB4-A79, and VB4-P5. The company was founded by Karen Duggan on December 12, 2005 and is headquartered in North Ryde, Australia.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of VBS is 0.080 AUD — it hasn't changed in the past 24 hours. Watch VECTUS BIOSYSTEMS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange VECTUS BIOSYSTEMS LIMITED stocks are traded under the ticker VBS.
VBS stock hasn't changed in a week, the month change is a 5.26% rise, over the last year VECTUS BIOSYSTEMS LIMITED has showed a −68.00% decrease.
VBS stock is 0.00% volatile and has beta coefficient of −1.29. Track VECTUS BIOSYSTEMS LIMITED stock price on the chart and check out the list of the most volatile stocks — is VECTUS BIOSYSTEMS LIMITED there?
Today VECTUS BIOSYSTEMS LIMITED has the market capitalization of 4.26 M, it has increased by 5.26% over the last week.
Yes, you can track VECTUS BIOSYSTEMS LIMITED financials in yearly and quarterly reports right on TradingView.
VBS net income for the last half-year is −1.10 M AUD, while the previous report showed −1.16 M AUD of net income which accounts for 5.16% change. Track more VECTUS BIOSYSTEMS LIMITED financial stats to get the full picture.
No, VBS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, VBS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VECTUS BIOSYSTEMS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VECTUS BIOSYSTEMS LIMITED technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VECTUS BIOSYSTEMS LIMITED stock shows the neutral signal. See more of VECTUS BIOSYSTEMS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.